Quarterly report pursuant to Section 13 or 15(d)

The Company and Summary of Significant Accounting Policies (Details Narrative)

v2.4.0.6
The Company and Summary of Significant Accounting Policies (Details Narrative) (USD $)
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Research and development expense $ 0 $ 49,000
Accumulated deficit (86,805,000)  
Cash and cash equivalent 5,000  
Stock options granted 26,384,193 1,527,778
Expected volatility 116.00%  
Expected dividend yield $ 0  
Share based compensation expense $ 421,000 $ 60,000
Diluted shares excluded from calcuation of EPS 595,753,204  
MinimumMember
   
Risk free interest rate 1.04%  
Expected life 5 years  
Amortized over vesting period 1 year  
MaximumMember
   
Risk free interest rate 2.04%  
Expected life 10 years  
Amortized over vesting period 4 years